Vitiligo is an acquired, chronic condition characterised by depigmentation of the epidermis
or by destruction/loss of melanin. Skin cells (melanocytes) are responsible for producing …

Vitiligo is a multifactorial disease characterized by the loss of skin pigment, which results in
achromic macules and patches. There are currently several medical treatments available …

Vitiligo, a common depigmenting cutaneous condition, is thought to affect 0.5%-2% of the
world's population. During this condition, melanocytes are selectively lost, resulting in non …

Exposure to sun radiation leads to higher risk of sunburn, pigmentation,
immunosuppression, photoaging and skin cancer. In addition to ultraviolet radiation (UVR) …

Vitiligo, the most prevalent skin depigmenting disease, is characterized by the selective loss
of melanocytes, impacting patients' quality of life significantly. This autoimmune disorder …

There is no first-line treatment for vitiligo, a skin disease characterized by a lack of melanin
produced by the melanocytes, resulting in an urgent demand for new therapeutic drugs …

Vitiligo has a complex multifactorial etiology involving a T-cell mediated autoimmune
response to cutaneous melanocytes. Microbial dysbiosis has been assigned a contributing …

Vitiligo is a chronic cutaneous disorder characterized by skin and hair depigmentation.
Drugs that are currently used to treat vitiligo lack of efficacy and had low local accumulation …

Vitiligo is a common skin disorder where melanocytes, the cells that produce skin pigment,
are destroyed by the immune system, leading to white patches on the skin and mucous …

Vitiligo is an autoimmune disease that spreads depigmented patches on the skin and has a
negative impact on a patient's mental health, physical health, and quality of life. It is a …